Evidence map›Paper›PMID 31399403›Full record

ArticleApplied and environmental microbiology2019

The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory

Dhana Thomy, Elizabeth Culp, Martina Adamek, Eric Y Cheng, Nadine Ziemert, Gerard D Wright, Peter Sass, Heike Brötz-Oesterhelt

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. ClpP2 modulates ClpXP assembly to promote multiple pathogenic phenotypes inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Generation of Lasso Peptide-Based ClpP Binders.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Dhana ThomyDepartment of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany.
Elizabeth CulpM. G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, Ontario, Canada.
Martina AdamekDepartment of Applied Natural Products Genome Mining, Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany.
Eric Y ChengUNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Nadine ZiemertDepartment of Applied Natural Products Genome Mining, Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany.
Gerard D WrightM. G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, Ontario, Canada.
Peter SassDepartment of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany.
Heike Brötz-OesterheltDepartment of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany heike.broetz-oesterhelt@uni-tuebingen.de.
University of Tübingen · DEMcMaster University · CAUniversity of North Texas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing threat posed by multiresistant bacterial pathogens necessitates the discovery of novel antibacterials with unprecedented modes of action. ADEP1, a natural compound produced by

Indexed as

Multigene FamilyAnti-Bacterial AgentsBiosynthetic PathwaysCloning, MolecularDepsipeptidesDNA Transposable ElementsDrug Resistance, BacterialDrug Resistance, MicrobialMicrobial Sensitivity TestsPeptide SynthasesPolyketide SynthasesStreptomycesStructure-Activity RelationshipADEP1 compoundAnti-Bacterial AgentsDepsipeptidesDNA Transposable Elementsnon-ribosomal peptide synthasePeptide SynthasesPolyketide Synthases4-methylprolineacyldepsipeptidesantibioticscaseinolytic proteasenatural productsnonribosomal peptide synthetasepolyketide synthaseresistancestreptomycetes

Identifiers

PMID31399403
PMCPMC6805094
OpenAlexW2966163101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.